10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

HAZ (Haemonetics) Stock Analysis
Buy, Hold or Sell?

Let's analyze Haemonetics together

I guess you are interested in Haemonetics Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Haemonetics’s Financial Insights
  • 📈 Technical Analysis (TA) – Haemonetics’s Price Targets

I'm going to help you getting a better view of Haemonetics Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Haemonetics Corporation

I send you an email if I find something interesting about Haemonetics Corporation.

1. Quick Overview

1.1. Quick analysis of Haemonetics (30 sec.)










1.2. What can you expect buying and holding a share of Haemonetics? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€15.55
Expected worth in 1 year
€16.06
How sure are you?
67.6%

+ What do you gain per year?

Total Gains per Share
€0.51
Return On Investment
1.2%

For what price can you sell your share?

Current Price per Share
€42.60
Expected price per share
€0 - €47.40
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Haemonetics (5 min.)




Live pricePrice per Share (EOD)
€42.60
Intrinsic Value Per Share
€33.22 - €38.89
Total Value Per Share
€48.77 - €54.45

2.2. Growth of Haemonetics (5 min.)




Is Haemonetics growing?

Current yearPrevious yearGrowGrow %
How rich?$882.2m$925.5m-$53.3m-6.1%

How much money is Haemonetics making?

Current yearPrevious yearGrowGrow %
Making money$40.8m$28.7m$12.1m29.7%
Net Profit Margin12.2%8.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Haemonetics (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Haemonetics?

Welcome investor! Haemonetics's management wants to use your money to grow the business. In return you get a share of Haemonetics.

First you should know what it really means to hold a share of Haemonetics. And how you can make/lose money.

Speculation

The Price per Share of Haemonetics is €42.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Haemonetics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Haemonetics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €15.55. Based on the TTM, the Book Value Change Per Share is €0.13 per quarter. Based on the YOY, the Book Value Change Per Share is €0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Haemonetics.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.711.7%0.832.0%0.561.3%0.711.7%0.561.3%0.411.0%
Usd Book Value Change Per Share1.273.0%0.150.4%0.160.4%0.270.6%0.310.7%0.541.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.273.0%0.150.4%0.160.4%0.270.6%0.310.7%0.541.3%
Usd Price Per Share72.95-78.24-92.66-86.33-83.58-84.84-
Price to Earnings Ratio25.84-25.17-43.58-33.06-18.58-8.59-
Price-to-Total Gains Ratio57.23--47.04-119.82-39.19-86.33-49.93-
Price to Book Ratio3.99-4.42-5.10-5.05-5.29-5.81-
Price-to-Total Gains Ratio57.23--47.04-119.82-39.19-86.33-49.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share50.12316
Number of shares19
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.150.31
Usd Total Gains Per Share0.150.31
Gains per Quarter (19 shares)2.855.97
Gains per Year (19 shares)11.3923.90
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1011102414
20231204838
30342307262
40463409686
5057450119110
6068560143134
7080670167158
8091780191182
90103890215206
1001141000239230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%28.06.00.082.4%28.06.00.082.4%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%15.05.00.075.0%23.011.00.067.6%23.011.00.067.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%15.05.00.075.0%23.011.00.067.6%23.011.00.067.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Haemonetics Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.0830.127+750%0.138+687%0.233+366%0.267+305%0.457+137%
Book Value Per Share--15.55215.047+3%15.466+1%14.623+6%13.560+15%12.875+21%
Current Ratio--1.7182.699-36%3.130-45%2.967-42%2.851-40%2.611-34%
Debt To Asset Ratio--0.6420.650-1%0.583+10%0.606+6%0.593+8%0.539+19%
Debt To Equity Ratio--1.7911.860-4%1.419+26%1.561+15%1.488+20%1.240+44%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--1646718817.4001905646525.725-14%2890746231.750-43%2549575053.867-35%2569941151.300-36%2785850255.521-41%
Eps--0.6000.707-15%0.480+25%0.6020%0.472+27%0.347+73%
Ev To Sales Ratio--1.5071.658-9%2.557-41%2.323-35%2.688-44%3.162-52%
Free Cash Flow Per Share--0.2400.820-71%0.372-35%0.643-63%0.502-52%0.487-51%
Free Cash Flow To Equity Per Share--0.197-0.168+185%1.920-90%0.723-73%0.700-72%0.789-75%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--38.894----------
Intrinsic Value_10Y_min--33.218----------
Intrinsic Value_1Y_max--2.766----------
Intrinsic Value_1Y_min--2.717----------
Intrinsic Value_3Y_max--9.174----------
Intrinsic Value_3Y_min--8.741----------
Intrinsic Value_5Y_max--16.621----------
Intrinsic Value_5Y_min--15.353----------
Market Cap2052352980.000-46%2989385738.0003282630921.000-9%4005382645.125-25%3695474967.917-19%3593977289.785-17%3592888673.653-17%
Net Profit Margin--0.1060.122-13%0.086+23%0.107-1%0.092+15%0.071+50%
Operating Margin----0%-0%0.039-100%0.072-100%0.088-100%
Operating Ratio--1.2341.270-3%1.364-9%1.280-4%1.341-8%1.349-9%
Pb Ratio2.739-46%3.9874.418-10%5.099-22%5.048-21%5.289-25%5.808-31%
Pe Ratio17.754-46%25.83925.166+3%43.585-41%33.064-22%18.582+39%8.587+201%
Price Per Share42.600-46%62.00066.500-7%78.750-21%73.375-16%71.035-13%72.104-14%
Price To Free Cash Flow Ratio44.292-46%64.46332.704+97%-12.308+119%22.107+192%-1.724+103%8.283+678%
Price To Total Gains Ratio39.320-46%57.226-47.037+182%119.823-52%39.192+46%86.326-34%49.927+15%
Quick Ratio--0.3780.586-36%0.733-48%0.682-45%0.627-40%0.633-40%
Return On Assets--0.0140.016-16%0.013+8%0.016-12%0.014+1%0.011+22%
Return On Equity--0.0390.047-18%0.031+24%0.040-5%0.034+15%0.026+47%
Total Gains Per Share--1.0830.127+750%0.138+687%0.233+366%0.267+305%0.457+137%
Usd Book Value--882293241.582872205068.858+1%925569410.084-5%864889541.562+2%806181324.604+9%754229251.971+17%
Usd Book Value Change Per Share--1.2750.150+750%0.162+687%0.274+366%0.314+305%0.538+137%
Usd Book Value Per Share--18.29917.705+3%18.197+1%17.205+6%15.955+15%15.148+21%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--1937529360.5532242183702.168-14%3401252016.277-43%2999830008.380-35%3023792758.620-36%3277831410.646-41%
Usd Eps--0.7060.832-15%0.564+25%0.7090%0.555+27%0.408+73%
Usd Free Cash Flow--13640895.51047290887.749-71%22123830.530-38%37785127.230-64%29667472.745-54%18624269.102-27%
Usd Free Cash Flow Per Share--0.2830.965-71%0.437-35%0.756-63%0.591-52%0.573-51%
Usd Free Cash Flow To Equity Per Share--0.232-0.198+185%2.259-90%0.850-73%0.824-72%0.929-75%
Usd Market Cap2414798516.268-46%3517311259.3313862343541.649-9%4712733220.254-25%4348095847.251-19%4228673679.161-17%4227392813.420-17%
Usd Price Per Share50.123-46%72.94978.244-7%92.657-21%86.333-16%83.580-13%84.838-14%
Usd Profit--34030739.32340833937.210-17%28722029.988+18%34565735.224-2%27349090.504+24%20102493.073+69%
Usd Revenue--321391538.122336508922.322-4%333471195.591-4%324870428.140-1%291398517.870+10%267987329.554+20%
Usd Total Gains Per Share--1.2750.150+750%0.162+687%0.274+366%0.314+305%0.538+137%
 EOD+4 -4MRQTTM+15 -20YOY+16 -193Y+12 -245Y+17 -1910Y+18 -18

3.3 Fundamental Score

Let's check the fundamental score of Haemonetics Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.754
Price to Book Ratio (EOD)Between0-12.739
Net Profit Margin (MRQ)Greater than00.106
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.378
Current Ratio (MRQ)Greater than11.718
Debt to Asset Ratio (MRQ)Less than10.642
Debt to Equity Ratio (MRQ)Less than11.791
Return on Equity (MRQ)Greater than0.150.039
Return on Assets (MRQ)Greater than0.050.014
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Haemonetics Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.157
Ma 20Greater thanMa 5045.420
Ma 50Greater thanMa 10053.496
Ma 100Greater thanMa 20056.728
OpenGreater thanClose43.800
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Haemonetics Corporation

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE closure products comprising VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, clinical specialists, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2025-08-19 19:03:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Haemonetics earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Haemonetics to the Medical Devices industry mean.
  • A Net Profit Margin of 10.6% means that €0.11 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Haemonetics Corporation:

  • The MRQ is 10.6%. The company is making a huge profit. +2
  • The TTM is 12.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.6%TTM12.2%-1.6%
TTM12.2%YOY8.6%+3.6%
TTM12.2%5Y9.2%+3.0%
5Y9.2%10Y7.1%+2.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ10.6%-10.9%+21.5%
TTM12.2%-10.0%+22.2%
YOY8.6%-14.9%+23.5%
3Y10.7%-13.7%+24.4%
5Y9.2%-12.2%+21.4%
10Y7.1%-12.2%+19.3%
4.3.1.2. Return on Assets

Shows how efficient Haemonetics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Haemonetics to the Medical Devices industry mean.
  • 1.4% Return on Assets means that Haemonetics generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Haemonetics Corporation:

  • The MRQ is 1.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.4%TTM1.6%-0.3%
TTM1.6%YOY1.3%+0.4%
TTM1.6%5Y1.4%+0.3%
5Y1.4%10Y1.1%+0.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4%-1.7%+3.1%
TTM1.6%-2.1%+3.7%
YOY1.3%-3.3%+4.6%
3Y1.6%-2.9%+4.5%
5Y1.4%-2.5%+3.9%
10Y1.1%-3.1%+4.2%
4.3.1.3. Return on Equity

Shows how efficient Haemonetics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Haemonetics to the Medical Devices industry mean.
  • 3.9% Return on Equity means Haemonetics generated €0.04 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Haemonetics Corporation:

  • The MRQ is 3.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.9%TTM4.7%-0.9%
TTM4.7%YOY3.1%+1.6%
TTM4.7%5Y3.4%+1.4%
5Y3.4%10Y2.6%+0.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9%-2.0%+5.9%
TTM4.7%-2.0%+6.7%
YOY3.1%-4.0%+7.1%
3Y4.0%-4.4%+8.4%
5Y3.4%-4.3%+7.7%
10Y2.6%-5.7%+8.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Haemonetics Corporation.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Haemonetics is operating .

  • Measures how much profit Haemonetics makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Haemonetics to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Haemonetics Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y7.2%-7.2%
5Y7.2%10Y8.8%-1.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--18.2%+18.2%
TTM--13.5%+13.5%
YOY--15.3%+15.3%
3Y3.9%-13.6%+17.5%
5Y7.2%-11.4%+18.6%
10Y8.8%-15.8%+24.6%
4.3.2.2. Operating Ratio

Measures how efficient Haemonetics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.23 means that the operating costs are €1.23 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Haemonetics Corporation:

  • The MRQ is 1.234. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.270. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.234TTM1.270-0.036
TTM1.270YOY1.364-0.094
TTM1.2705Y1.341-0.071
5Y1.34110Y1.349-0.008
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2341.320-0.086
TTM1.2701.308-0.038
YOY1.3641.221+0.143
3Y1.2801.288-0.008
5Y1.3411.312+0.029
10Y1.3491.320+0.029
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Haemonetics Corporation.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Haemonetics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.72 means the company has €1.72 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Haemonetics Corporation:

  • The MRQ is 1.718. The company is able to pay all its short-term debts. +1
  • The TTM is 2.699. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.718TTM2.699-0.981
TTM2.699YOY3.130-0.431
TTM2.6995Y2.851-0.151
5Y2.85110Y2.611+0.240
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7182.474-0.756
TTM2.6992.594+0.105
YOY3.1302.697+0.433
3Y2.9672.885+0.082
5Y2.8513.528-0.677
10Y2.6113.426-0.815
4.4.3.2. Quick Ratio

Measures if Haemonetics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Haemonetics to the Medical Devices industry mean.
  • A Quick Ratio of 0.38 means the company can pay off €0.38 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Haemonetics Corporation:

  • The MRQ is 0.378. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.586. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.378TTM0.586-0.208
TTM0.586YOY0.733-0.146
TTM0.5865Y0.627-0.041
5Y0.62710Y0.633-0.006
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3781.350-0.972
TTM0.5861.553-0.967
YOY0.7331.706-0.973
3Y0.6821.905-1.223
5Y0.6272.225-1.598
10Y0.6332.519-1.886
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Haemonetics Corporation.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Haemonetics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Haemonetics to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.64 means that Haemonetics assets are financed with 64.2% credit (debt) and the remaining percentage (100% - 64.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Haemonetics Corporation:

  • The MRQ is 0.642. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.650. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.642TTM0.650-0.008
TTM0.650YOY0.583+0.067
TTM0.6505Y0.593+0.057
5Y0.59310Y0.539+0.054
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6420.408+0.234
TTM0.6500.414+0.236
YOY0.5830.400+0.183
3Y0.6060.397+0.209
5Y0.5930.420+0.173
10Y0.5390.456+0.083
4.5.4.2. Debt to Equity Ratio

Measures if Haemonetics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Haemonetics to the Medical Devices industry mean.
  • A Debt to Equity ratio of 179.1% means that company has €1.79 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Haemonetics Corporation:

  • The MRQ is 1.791. The company is just able to pay all its debts with equity.
  • The TTM is 1.860. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.791TTM1.860-0.070
TTM1.860YOY1.419+0.441
TTM1.8605Y1.488+0.373
5Y1.48810Y1.240+0.247
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7910.631+1.160
TTM1.8600.646+1.214
YOY1.4190.605+0.814
3Y1.5610.640+0.921
5Y1.4880.649+0.839
10Y1.2400.769+0.471
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Haemonetics generates.

  • Above 15 is considered overpriced but always compare Haemonetics to the Medical Devices industry mean.
  • A PE ratio of 25.84 means the investor is paying €25.84 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Haemonetics Corporation:

  • The EOD is 17.754. Based on the earnings, the company is fair priced.
  • The MRQ is 25.839. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.166. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD17.754MRQ25.839-8.085
MRQ25.839TTM25.166+0.673
TTM25.166YOY43.585-18.419
TTM25.1665Y18.582+6.584
5Y18.58210Y8.587+9.994
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD17.754-1.141+18.895
MRQ25.839-1.287+27.126
TTM25.166-1.277+26.443
YOY43.585-2.876+46.461
3Y33.064-1.561+34.625
5Y18.582-2.137+20.719
10Y8.587-1.811+10.398
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Haemonetics Corporation:

  • The EOD is 44.292. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 64.463. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 32.704. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD44.292MRQ64.463-20.171
MRQ64.463TTM32.704+31.759
TTM32.704YOY-12.308+45.012
TTM32.7045Y-1.724+34.428
5Y-1.72410Y8.283-10.007
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD44.292-1.848+46.140
MRQ64.463-2.063+66.526
TTM32.704-1.841+34.545
YOY-12.308-3.187-9.121
3Y22.107-2.200+24.307
5Y-1.724-4.000+2.276
10Y8.283-4.000+12.283
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Haemonetics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 3.99 means the investor is paying €3.99 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Haemonetics Corporation:

  • The EOD is 2.739. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.987. Based on the equity, the company is fair priced.
  • The TTM is 4.418. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.739MRQ3.987-1.247
MRQ3.987TTM4.418-0.431
TTM4.418YOY5.099-0.681
TTM4.4185Y5.289-0.872
5Y5.28910Y5.808-0.519
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.7392.280+0.459
MRQ3.9872.158+1.829
TTM4.4182.203+2.215
YOY5.0992.683+2.416
3Y5.0482.683+2.365
5Y5.2893.687+1.602
10Y5.8084.207+1.601
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets2,462,094
Total Liabilities1,579,794
Total Stockholder Equity882,300
 As reported
Total Liabilities 1,579,794
Total Stockholder Equity+ 882,300
Total Assets = 2,462,094

Assets

Total Assets2,462,094
Total Current Assets913,160
Long-term Assets1,548,934
Total Current Assets
Cash And Cash Equivalents 292,898
Net Receivables 200,752
Inventory 360,527
Other Current Assets 58,983
Total Current Assets  (as reported)913,160
Total Current Assets  (calculated)913,160
+/-0
Long-term Assets
Property Plant Equipment 286,865
Goodwill 607,299
Intangible Assets 450,634
Long-term Assets Other 196,293
Long-term Assets  (as reported)1,548,934
Long-term Assets  (calculated)1,541,091
+/- 7,843

Liabilities & Shareholders' Equity

Total Current Liabilities531,407
Long-term Liabilities1,048,387
Total Stockholder Equity882,300
Total Current Liabilities
Short Long Term Debt 303,949
Accounts payable 46,010
Other Current Liabilities 145,643
Total Current Liabilities  (as reported)531,407
Total Current Liabilities  (calculated)495,602
+/- 35,805
Long-term Liabilities
Long term Debt 920,833
Long-term Liabilities Other 68,066
Long-term Liabilities  (as reported)1,048,387
Long-term Liabilities  (calculated)988,899
+/- 59,488
Total Stockholder Equity
Retained Earnings 356,046
Total Stockholder Equity (as reported)882,300
Total Stockholder Equity (calculated)356,046
+/- 526,254
Other
Capital Stock482
Common Stock Shares Outstanding 48,216
Net Debt 931,884
Net Invested Capital 2,107,082
Net Working Capital 381,753
Property Plant and Equipment Gross 795,098



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
1,238,709
1,251,382
1,271,163
1,311,714
1,237,339
1,241,168
1,265,711
1,227,637
1,274,767
1,259,610
1,190,541
1,237,749
1,267,110
1,433,173
1,418,174
1,318,068
1,819,923
1,794,187
1,801,497
1,831,376
1,859,734
1,820,526
1,865,112
1,878,066
1,934,825
1,962,258
2,011,275
2,200,428
2,195,591
2,540,977
2,525,224
2,531,270
2,450,948
2,462,094
2,462,0942,450,9482,531,2702,525,2242,540,9772,195,5912,200,4282,011,2751,962,2581,934,8251,878,0661,865,1121,820,5261,859,7341,831,3761,801,4971,794,1871,819,9231,318,0681,418,1741,433,1731,267,1101,237,7491,190,5411,259,6101,274,7671,227,6371,265,7111,241,1681,237,3391,311,7141,271,1631,251,3821,238,709
   > Total Current Assets 
510,029
528,089
553,389
589,713
521,177
551,017
552,805
515,897
576,121
615,278
567,789
582,575
603,639
759,410
760,279
668,348
693,546
684,368
699,246
729,455
756,031
687,783
715,789
706,309
769,722
801,607
865,744
764,982
768,903
978,578
955,902
1,005,868
934,975
913,160
913,160934,9751,005,868955,902978,578768,903764,982865,744801,607769,722706,309715,789687,783756,031729,455699,246684,368693,546668,348760,279759,410603,639582,575567,789615,278576,121515,897552,805551,017521,177589,713553,389528,089510,029
       Cash And Cash Equivalents 
139,564
171,739
203,622
251,591
180,169
192,106
199,763
154,871
169,351
190,234
112,030
126,417
137,311
275,725
279,169
189,002
192,305
173,462
192,420
236,877
259,496
214,948
241,200
224,002
284,466
285,719
351,005
193,978
178,800
344,429
299,283
320,846
306,763
292,898
292,898306,763320,846299,283344,429178,800193,978351,005285,719284,466224,002241,200214,948259,496236,877192,420173,462192,305189,002279,169275,725137,311126,417112,030190,234169,351154,871199,763192,106180,169251,591203,622171,739139,564
       Net Receivables 
152,683
151,507
143,693
146,718
151,226
151,336
161,590
167,641
185,027
163,339
176,535
170,753
165,207
141,094
141,533
146,939
127,555
132,908
141,305
154,980
159,376
146,463
171,532
181,100
179,142
177,117
174,249
211,611
206,562
201,485
213,534
211,949
202,657
200,752
200,752202,657211,949213,534201,485206,562211,611174,249177,117179,142181,100171,532146,463159,376154,980141,305132,908127,555146,939141,533141,094165,207170,753176,535163,339185,027167,641161,590151,336151,226146,718143,693151,507152,683
       Inventory 
176,929
173,894
168,592
158,840
160,799
175,329
163,584
168,936
194,337
221,953
244,504
254,167
270,276
294,510
305,224
299,710
322,614
326,500
322,661
305,741
293,027
277,887
254,680
255,756
259,379
289,207
285,830
304,024
317,202
373,787
382,105
359,614
365,141
360,527
360,527365,141359,614382,105373,787317,202304,024285,830289,207259,379255,756254,680277,887293,027305,741322,661326,500322,614299,710305,224294,510270,276254,167244,504221,953194,337168,936163,584175,329160,799158,840168,592173,894176,929
       Other Current Assets 
40,853
1,729
1,157
443
1,104
1,638
2,620
1,755
1,277
591
34,720
642
1,216
391
478
260
2,165
1,862
1,515
1,724
3,232
4,638
4,313
1,104
46,735
2,618
54,660
55,369
66,339
58,877
60,980
113,459
60,414
58,983
58,98360,414113,45960,98058,87766,33955,36954,6602,61846,7351,1044,3134,6383,2321,7241,5151,8622,1652604783911,21664234,7205911,2771,7552,6201,6381,1044431,1571,72940,853
   > Long-term Assets 
0
0
0
0
0
0
0
0
698,646
644,332
622,752
655,174
663,471
673,763
657,895
649,720
1,126,377
1,109,819
1,102,251
1,101,921
1,103,703
1,132,743
1,149,323
1,171,757
1,165,103
1,160,651
1,145,531
1,435,446
1,426,688
1,562,399
1,569,322
1,525,402
1,515,972
1,548,934
1,548,9341,515,9721,525,4021,569,3221,562,3991,426,6881,435,4461,145,5311,160,6511,165,1031,171,7571,149,3231,132,7431,103,7031,101,9211,102,2511,109,8191,126,377649,720657,895673,763663,471655,174622,752644,332698,64600000000
       Property Plant Equipment 
323,862
321,953
320,221
330,026
332,156
315,873
344,560
351,108
343,979
297,965
283,594
322,262
305,635
242,969
240,405
240,009
277,415
214,782
223,747
238,841
311,231
288,321
307,844
313,138
310,885
304,467
307,766
318,665
311,362
302,480
300,478
286,107
284,052
286,865
286,865284,052286,107300,478302,480311,362318,665307,766304,467310,885313,138307,844288,321311,231238,841223,747214,782277,415240,009240,405242,969305,635322,262283,594297,965343,979351,108344,560315,873332,156330,026320,221321,953323,862
       Goodwill 
210,841
210,930
211,125
211,086
211,395
210,903
210,844
210,723
210,819
211,140
211,041
211,062
210,652
217,298
214,594
215,508
466,444
466,314
468,590
468,199
467,287
466,115
464,987
466,112
466,231
465,910
465,405
554,999
565,082
613,347
616,162
605,266
604,269
607,299
607,299604,269605,266616,162613,347565,082554,999465,405465,910466,231466,112464,987466,115467,287468,199468,590466,314466,444215,508214,594217,298210,652211,062211,041211,140210,819210,723210,844210,903211,395211,086211,125210,930210,841
       Intangible Assets 
177,540
173,420
169,379
163,946
156,589
148,730
141,483
134,724
127,693
120,340
113,540
107,307
133,106
137,520
127,210
119,716
365,483
353,688
337,249
323,951
310,261
302,710
292,595
284,383
275,771
268,146
250,504
429,270
406,117
494,935
487,837
465,615
455,742
450,634
450,634455,742465,615487,837494,935406,117429,270250,504268,146275,771284,383292,595302,710310,261323,951337,249353,688365,483119,716127,210137,520133,106107,307113,540120,340127,693134,724141,483148,730156,589163,946169,379173,420177,540
       Long-term Assets Other 
0
0
0
0
0
0
0
0
11,796
31,482
29,605
64,273
62,384
71,888
71,380
69,929
76,891
68,838
66,601
64,880
67,673
71,045
83,897
103,282
106,975
117,253
117,111
127,442
136,388
142,268
155,762
160,414
164,106
196,293
196,293164,106160,414155,762142,268136,388127,442117,111117,253106,975103,28283,89771,04567,67364,88066,60168,83876,89169,92971,38071,88862,38464,27329,60531,48211,79600000000
> Total Liabilities 
499,099
478,612
469,910
488,907
484,910
567,109
564,373
584,508
606,899
668,644
606,787
663,169
680,001
824,604
750,251
598,916
1,088,253
1,117,107
1,102,948
1,100,601
1,110,310
1,050,103
1,136,103
1,102,087
1,116,828
1,097,642
1,117,615
1,257,109
1,235,632
1,635,609
1,646,373
1,624,410
1,630,112
1,579,794
1,579,7941,630,1121,624,4101,646,3731,635,6091,235,6321,257,1091,117,6151,097,6421,116,8281,102,0871,136,1031,050,1031,110,3101,100,6011,102,9481,117,1071,088,253598,916750,251824,604680,001663,169606,787668,644606,899584,508564,373567,109484,910488,907469,910478,612499,099
   > Total Current Liabilities 
211,179
205,523
254,999
324,178
384,703
193,995
189,167
211,282
235,759
293,665
240,066
256,692
274,822
407,827
338,568
194,384
253,495
228,339
288,470
355,411
442,266
180,487
262,175
226,889
251,816
236,939
264,215
261,755
300,383
260,076
273,946
253,233
578,113
531,407
531,407578,113253,233273,946260,076300,383261,755264,215236,939251,816226,889262,175180,487442,266355,411288,470228,339253,495194,384338,568407,827274,822256,692240,066293,665235,759211,282189,167193,995384,703324,178254,999205,523211,179
       Short-term Debt 
61,022
303,043
108,589
151,465
194,259
17,043
12,664
20,040
27,666
117,548
56,934
61,966
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000061,96656,934117,54827,66620,04012,66417,043194,259151,465108,589303,04361,022
       Short Long Term Debt 
61,022
303,043
108,589
151,465
194,259
17,043
12,664
20,040
27,666
117,548
56,934
61,966
76,980
231,364
167,001
17,055
17,016
17,025
82,733
144,064
214,148
6,853
58,194
9,949
11,784
13,572
13,566
13,736
10,229
5,109
5,434
5,075
303,558
303,949
303,949303,5585,0755,4345,10910,22913,73613,56613,57211,7849,94958,1946,853214,148144,06482,73317,02517,01617,055167,001231,36476,98061,96656,934117,54827,66620,04012,66417,043194,259151,465108,589303,04361,022
       Accounts payable 
86,507
39,389
41,764
41,496
55,265
65,393
57,857
62,579
63,361
60,792
57,449
52,298
50,730
48,459
49,071
42,979
50,293
49,131
44,969
51,175
58,371
57,907
61,484
63,769
63,929
78,134
80,160
56,845
73,358
76,929
69,242
62,990
66,999
46,010
46,01066,99962,99069,24276,92973,35856,84580,16078,13463,92963,76961,48457,90758,37151,17544,96949,13150,29342,97949,07148,45950,73052,29857,44960,79263,36162,57957,85765,39355,26541,49641,76439,38986,507
       Other Current Liabilities 
63,650
68,324
67,282
68,151
62,728
65,731
69,514
76,852
51,807
83,973
86,835
83,580
81,475
85,720
87,136
93,526
120,897
122,271
114,249
116,660
108,517
85,305
97,741
100,989
81,419
112,263
124,851
132,412
104,846
137,270
149,970
139,235
104,785
145,643
145,643104,785139,235149,970137,270104,846132,412124,851112,26381,419100,98997,74185,305108,517116,660114,249122,271120,89793,52687,13685,72081,47583,58086,83583,97351,80776,85269,51465,73162,72868,15167,28268,32463,650
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
371,140
374,979
366,721
406,477
405,179
416,777
411,683
404,532
834,758
888,768
814,478
745,190
668,044
869,616
873,928
875,198
865,012
860,703
853,400
995,354
935,249
1,375,533
1,372,427
1,371,177
1,051,999
1,048,387
1,048,3871,051,9991,371,1771,372,4271,375,533935,249995,354853,400860,703865,012875,198873,928869,616668,044745,190814,478888,768834,758404,532411,683416,777405,179406,477366,721374,979371,14000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
59,320
0
0
0
70,668
0
0
0
7,196
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000007,19600070,66800059,320000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
5,814
42,829
41,050
82,163
5,721
106,768
104,187
102,008
144,166
97,145
91,861
85,940
108,603
73,853
114,376
78,220
74,715
71,980
69,931
76,259
75,041
92,263
90,011
89,964
68,194
68,066
68,06668,19489,96490,01192,26375,04176,25969,93171,98074,71578,220114,37673,853108,60385,94091,86197,145144,166102,008104,187106,7685,72182,16341,05042,8295,81400000000
       Deferred Long Term Liability 
12,114
12,818
13,380
6,428
6,526
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000006,5266,42813,38012,81812,114
> Total Stockholder Equity
739,610
772,770
801,253
822,807
752,429
674,059
701,338
643,129
667,868
590,966
583,754
574,580
587,109
608,569
667,923
719,152
731,670
677,080
698,549
730,775
749,424
770,423
729,009
775,979
817,997
864,616
893,660
943,319
959,959
905,368
878,851
906,860
820,836
882,300
882,300820,836906,860878,851905,368959,959943,319893,660864,616817,997775,979729,009770,423749,424730,775698,549677,080731,670719,152667,923608,569587,109574,580583,754590,966667,868643,129701,338674,059752,429822,807801,253772,770739,610
   Common Stock
523
525
527
534
523
516
516
510
510
508
506
504
503
507
507
508
509
510
511
511
511
513
506
504
0
507
0
0
0
0
0
0
0
0
000000005070504506513511511511510509508507507503504506508510510516516523534527525523
   Retained Earnings 
289,916
310,053
330,155
323,608
266,942
189,859
194,375
140,584
161,418
99,418
85,634
69,868
78,512
89,039
137,140
169,022
157,981
154,562
169,418
192,650
202,391
222,268
204,364
223,785
253,168
284,017
308,898
340,099
360,456
386,642
368,536
392,230
352,174
356,046
356,046352,174392,230368,536386,642360,456340,099308,898284,017253,168223,785204,364222,268202,391192,650169,418154,562157,981169,022137,14089,03978,51269,86885,63499,418161,418140,584194,375189,859266,942323,608330,155310,053289,916
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,360,824
Cost of Revenue-611,866
Gross Profit748,958748,958
 
Operating Income (+$)
Gross Profit748,958
Operating Expense-1,159,638
Operating Income201,186-410,680
 
Operating Expense (+$)
Research Development62,722
Selling General Administrative436,789
Selling And Marketing Expenses-
Operating Expense1,159,638499,511
 
Net Interest Income (+$)
Interest Income-
Interest Expense-9,746
Other Finance Cost-0
Net Interest Income-9,746
 
Pretax Income (+$)
Operating Income201,186
Net Interest Income-9,746
Other Non-Operating Income Expenses-
Income Before Tax (EBT)212,071180,555
EBIT - interestExpense = -9,746
167,679
177,425
Interest Expense9,746
Earnings Before Interest and Taxes (EBIT)-221,817
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax212,071
Tax Provision-44,392
Net Income From Continuing Ops167,679167,679
Net Income167,679
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net20,6319,746
 

Technical Analysis of Haemonetics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Haemonetics. The general trend of Haemonetics is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Haemonetics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Haemonetics Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Haemonetics Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 43.60 < 44.80 < 47.40.

The bearish price targets are: .

Know someone who trades $HAZ? Share this with them.👇

Haemonetics Corporation Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Haemonetics Corporation. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Haemonetics Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Haemonetics Corporation. The current macd is -2.3465286.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Haemonetics price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Haemonetics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Haemonetics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Haemonetics Corporation Daily Moving Average Convergence/Divergence (MACD) ChartHaemonetics Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Haemonetics Corporation. The current adx is 39.93.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Haemonetics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Haemonetics Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Haemonetics Corporation. The current sar is 46.35.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Haemonetics Corporation Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Haemonetics Corporation. The current rsi is 27.16. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Haemonetics Corporation Daily Relative Strength Index (RSI) ChartHaemonetics Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Haemonetics Corporation. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Haemonetics price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Haemonetics Corporation Daily Stochastic Oscillator ChartHaemonetics Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Haemonetics Corporation. The current cci is -269.25845932.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Haemonetics Corporation Daily Commodity Channel Index (CCI) ChartHaemonetics Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Haemonetics Corporation. The current cmo is -52.51480843.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Haemonetics Corporation Daily Chande Momentum Oscillator (CMO) ChartHaemonetics Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Haemonetics Corporation. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Haemonetics Corporation Daily Williams %R ChartHaemonetics Corporation Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Haemonetics Corporation.

Haemonetics Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Haemonetics Corporation. The current atr is 0.91655583.

Haemonetics Corporation Daily Average True Range (ATR) ChartHaemonetics Corporation Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Haemonetics Corporation. The current obv is -1,391.

Haemonetics Corporation Daily On-Balance Volume (OBV) ChartHaemonetics Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Haemonetics Corporation. The current mfi is 38.86.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Haemonetics Corporation Daily Money Flow Index (MFI) ChartHaemonetics Corporation Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Haemonetics Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-29 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-07 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-08 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-21 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-23 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-06 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-09 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-11 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-13 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-17 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-03 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-16 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-17 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-18 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-24 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-29 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-30 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-07 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-08 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-22 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-26 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-04 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-12 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Haemonetics Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Haemonetics Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.157
Ma 20Greater thanMa 5045.420
Ma 50Greater thanMa 10053.496
Ma 100Greater thanMa 20056.728
OpenGreater thanClose43.800
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Haemonetics with someone you think should read this too:
  • Are you bullish or bearish on Haemonetics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Haemonetics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Haemonetics Corporation

I send you an email if I find something interesting about Haemonetics Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Haemonetics Corporation.

Receive notifications about Haemonetics Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.